Core Insights - The company achieved organic revenue growth of 13%, driven by new resident additions, increased script volumes, and a shift toward higher-acuity care [1] - Adjusted EBITDA margins expanded by 50 basis points despite the costs associated with becoming a public company and integrating early-stage acquisitions [1] - The company effectively managed challenges in the branded inhaler category due to the American Rescue Plan through disciplined operational execution [1] Clinical and Operational Highlights - Clinical value was demonstrated through over 100,000 interventions and an insurance optimization program that saved residents approximately $56 million [1] - Management credits its competitive advantage to a local service model that alleviates labor burdens for facility operators facing an aging population [1] - Strategic investments in 'Guardian Hub' and 'Guardian Note' messaging systems have enhanced real-time visibility and workflow efficiency for facility partners [1] Financial Strategy - The company maintains a disciplined capital allocation strategy, leveraging strong cash flow to fund four acquisitions and multiple greenfield startups without the need for external financing [1]

Fred Burke: Thank you, Ashley, and good afternoon, everyone. We appreciate your continued interest as we review another very strong quarter and year for Guardian Pharmacy Services, Inc. Turning briefly to the fourth quarter, we delivered results that exceeded our expectations across the board, reflecting solid execution throughout the organization. David will walk through the quarterly details in more depth. What I would like to focus on today is our full-year 2025 performance, including our key financial r ...